Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Oncotarget|July 23, 2016
ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasionTakashi Kawahara, Satoshi Inoue, Hiroki Ide, et al.Urologic Oncology|June 24, 2017
Low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naïve prostate cancerMari Ohtaka, Yasuhide Miyoshi, Takashi Kawahara, et al.Case Reports in Oncology|April 24, 2018
Fluorescent Light-Guided Cystoscopy with 5-ALA Aids in Accurate Surgical Margin Detection for TURBO: A Case ReportDaiji Takamoto, Takashi Kawahara, Shinji Ohtake, et al.Cancer Medicine|November 18, 2022
Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancerNeal Patel, Alexander Hakansson, Shinji Ohtake, et al.Hinyokika Kiyo. Acta Urologica Japonica|June 14, 2021
[A Case of Lymphoepithelioma-Like Carcinoma of the Ureter]Yuki Fujita, Atsuto Suzuki, Miho Asaoka, et al.Biomed Research International|November 9, 2016
Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin TherapyShinji Ohtake, Takashi Kawahara, Ryo Kasahara, et al.International Journal of Molecular Sciences|August 14, 2025
The Loss of Complex I in Renal Oncocytoma Is Associated with Defective Mitophagy Due to Lysosomal DysfunctionLin Lin, Neal Patel, Lucia Fernandez-Del-Rio, et al.BMC Cancer|March 6, 2016
Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomyTakashi Kawahara, Kazuhiro Furuya, Manami Nakamura, et al.Cancer Chemotherapy and Pharmacology|June 16, 2020
C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinomaGo Noguchi, Noboru Nakaigawa, Susumu Umemoto, et al.BMC Urology|November 8, 2018
PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancerTakashi Kawahara, Yukari Ishiguro, Shinji Ohtake, et al.Pageof 4